Sakar Other Liab vs Net Receivables Analysis
SAKAR Stock | 286.25 1.40 0.49% |
Sakar Healthcare financial indicator trend analysis is much more than just breaking down Sakar Healthcare prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sakar Healthcare is a good investment. Please check the relationship between Sakar Healthcare Other Liab and its Net Receivables accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sakar Healthcare Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Other Liab vs Net Receivables
Other Liab vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sakar Healthcare Other Liab account and Net Receivables. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Sakar Healthcare's Other Liab and Net Receivables is 0.87. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Sakar Healthcare Limited, assuming nothing else is changed. The correlation between historical values of Sakar Healthcare's Other Liab and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Sakar Healthcare Limited are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Other Liab i.e., Sakar Healthcare's Other Liab and Net Receivables go up and down completely randomly.
Correlation Coefficient | 0.87 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Other Liab
Net Receivables
Most indicators from Sakar Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sakar Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sakar Healthcare Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Sakar Healthcare's Selling General Administrative is very stable compared to the past year. As of the 23rd of November 2024, Issuance Of Capital Stock is likely to grow to about 402.7 M, while Tax Provision is likely to drop about 27.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 534.1M | 598.1M | 699.6M | 377.4M | Total Revenue | 1.3B | 1.3B | 1.5B | 812.9M |
Sakar Healthcare fundamental ratios Correlations
Click cells to compare fundamentals
Sakar Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sakar Healthcare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.2B | 1.8B | 2.7B | 3.4B | 4.0B | 4.1B | |
Short Long Term Debt Total | 167.0M | 426.0M | 928.6M | 1.1B | 793.5M | 456.4M | |
Other Current Liab | 4.9M | 22.4M | 52.9M | 37.4M | 41.9M | 28.2M | |
Total Current Liabilities | 142.4M | 332.7M | 467.6M | 544.9M | 590.6M | 620.1M | |
Total Stockholder Equity | 813.2M | 984.5M | 1.3B | 1.7B | 2.6B | 2.8B | |
Property Plant And Equipment Net | 893.7M | 1.4B | 2.2B | 2.7B | 3.1B | 3.3B | |
Net Debt | 164.0M | 425.1M | 928.3M | 1.1B | 790.9M | 453.3M | |
Retained Earnings | 310.0M | 409.4M | 558.9M | 688.6M | 805.4M | 845.6M | |
Accounts Payable | 54.4M | 197.8M | 305.0M | 260.9M | 274.5M | 288.3M | |
Cash | 3.0M | 824.6K | 298K | 933K | 2.6M | 2.2M | |
Non Current Assets Total | 934.7M | 1.4B | 2.2B | 2.8B | 3.2B | 3.3B | |
Non Currrent Assets Other | 8.2M | 8.2M | 1K | 70.3M | 21.4M | 12.0M | |
Other Assets | 146.8M | 260.5M | (1K) | 70.3M | 65.4M | 56.1M | |
Cash And Short Term Investments | 3.0M | 824.6K | 71.4M | 35.2M | 4.7M | 4.4M | |
Net Receivables | 82.3M | 123.7M | 141.8M | 220.8M | 209.1M | 121.3M | |
Common Stock Shares Outstanding | 15.0M | 150.8K | 15.1M | 18.6M | 20.5M | 12.9M | |
Liabilities And Stockholders Equity | 1.2B | 1.8B | 2.7B | 3.4B | 3.9B | 4.1B | |
Non Current Liabilities Total | 195.7M | 460.7M | 935.4M | 1.1B | 738.1M | 447.5M | |
Inventory | 109.3M | 157.0M | 141.8M | 154.0M | 280.6M | 294.7M | |
Other Current Assets | 21.1M | 55.7M | 145.2M | 149.2M | 225.0M | 236.3M | |
Other Stockholder Equity | 348.2M | 417.4M | 546.2M | 860.4M | 1.6B | 1.6B | |
Total Liab | 338.0M | 793.4M | 1.4B | 1.6B | 1.3B | 719.3M | |
Total Current Assets | 216.5M | 337.2M | 500.2M | 559.2M | 716.1M | 751.9M | |
Accumulated Other Comprehensive Income | 5.3M | (1.6M) | (3.9M) | (6.0M) | 40.9M | 43.0M | |
Short Term Debt | 41.4M | 41.5M | 78.5M | 187.4M | 213.8M | 224.5M | |
Other Liab | 70.9M | 76.2M | 85.3M | 102.7M | 118.1M | 79.5M | |
Net Tangible Assets | 780.4M | 977.2M | 1.3B | 1.7B | 2.0B | 2.1B | |
Current Deferred Revenue | 25.3M | 71.3M | 54.1M | 97.4M | 17.8M | 16.9M | |
Long Term Debt | 124.7M | 384.5M | 850.1M | 982.3M | 1.1B | 1.2B | |
Long Term Debt Total | 124.7M | 384.5M | 850.1M | 982.3M | 1.1B | 1.2B | |
Short Long Term Debt | 42.3M | 41.5M | 45.2M | 130.2M | 149.7M | 157.2M | |
Property Plant Equipment | 755.0M | 1.2B | 2.1B | 2.7B | 3.1B | 3.3B | |
Cash And Equivalents | 3.0M | 824.7K | 1K | 933K | 839.7K | 797.7K | |
Net Invested Capital | 980.2M | 1.4B | 2.2B | 2.8B | 3.3B | 3.4B | |
Net Working Capital | 74.1M | 4.5M | 32.6M | 14.2M | 12.8M | 12.2M | |
Intangible Assets | 53.8M | 32.8M | 7.3M | 0.0 | 14.6M | 15.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Sakar Stock
Balance Sheet is a snapshot of the financial position of Sakar Healthcare at a specified time, usually calculated after every quarter, six months, or one year. Sakar Healthcare Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Sakar Healthcare and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Sakar currently owns. An asset can also be divided into two categories, current and non-current.